HomeQuestion

Would you typically offer adjuvant FOLFOX or XELOX to a pT4b pN0 colon cancer?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you differentiate between ERBB2 mutation vs HER2 overexpression testing when selecting patients for tumor-agnostic therapy?

Why does NCCN still not recommend using circulating tumor DNA to guide adjuvant chemotherapy in stage II colon cancer when colon cancer experts are currently embracing the practice?

How would you treat an early-stage dMMR rectal squamous cell carcinoma in an otherwise healthy elderly patient?

Would you offer adjuvant therapy to a patient with a high grade mucinous appendiceal neoplasm that is pT3 pN0 M0, >12 lymph nodes removed with ileocecectomy?

Would you extend pembrolizumab for over 2 years in a patient with MSI-H pancreatic ductal adenocarcinoma with now-stable disease?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Would you typically offer adjuvant FOLFOX or XELOX to a pT4b pN0 colon cancer? | Mednet